DSM rises after in-line Q4 results
16/02/2023 09:03
** DSM DSMN.AS shares rise 2.6% as the Dutch chemical firm
reported Q4 results in line with expectations
** The chemical group achieved yearly sales of 8.39 billion
euros ($8.98 billion), falling roughly in line with estimates
according to a company-compiled consensus
** "The key for us today is that the company did not miss,"
Barclays says, adding that the environment has clearly
deteriorated in Q4 with most ingredients peers having missed
expectations
** The broker expects the Firmenich merger to be approved
soon, which would help turn the sentiment for DSM stock more
positive again and start closing the valuation gap to peers
($1 = 0.9339 euros)
(Reporting by Tristan Chabba and Ozan Ergenay)
((Tristan.chabba@thomsonreuters.com))